Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $548314.8.

  • Dr Reddys Laboratories' Shares Outstanding (Weighted Average) fell 503.4% to $548314.8 in Q4 2025 from the same period last year, while for Dec 2025 it was $548314.8, marking a year-over-year decrease of 503.4%. This contributed to the annual value of $3.4 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Shares Outstanding (Weighted Average) of $548314.8 as of Q4 2025, which was down 503.4% from $393144.8 recorded in Q3 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Shares Outstanding (Weighted Average) peaked at $3.3 million during Q1 2023, and registered a low of $199107.5 during Q2 2025.
  • In the last 5 years, Dr Reddys Laboratories' Shares Outstanding (Weighted Average) had a median value of $928021.2 in 2022 and averaged $1.2 million.
  • In the last 5 years, Dr Reddys Laboratories' Shares Outstanding (Weighted Average) skyrocketed by 9868.88% in 2022 and then crashed by 8190.13% in 2024.
  • Dr Reddys Laboratories' Shares Outstanding (Weighted Average) (Quarter) stood at $1.8 million in 2021, then surged by 42.53% to $2.6 million in 2022, then crashed by 76.36% to $615267.0 in 2023, then decreased by 6.16% to $577379.9 in 2024, then fell by 5.03% to $548314.8 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $548314.8 for Q4 2025, versus $393144.8 for Q3 2025 and $199107.5 for Q2 2025.